| Literature DB >> 28892482 |
Kellia Chiu1, Quinn Grundy1, Lisa Bero1.
Abstract
In the scientific literature, spin refers to reporting practices that distort the interpretation of results and mislead readers so that results are viewed in a more favourable light. The presence of spin in biomedical research can negatively impact the development of further studies, clinical practice, and health policies. This systematic review aims to explore the nature and prevalence of spin in the biomedical literature. We searched MEDLINE, PreMEDLINE, Embase, Scopus, and hand searched reference lists for all reports that included the measurement of spin in the biomedical literature for at least 1 outcome. Two independent coders extracted data on the characteristics of reports and their included studies and all spin-related outcomes. Results were grouped inductively into themes by spin-related outcome and are presented as a narrative synthesis. We used meta-analyses to analyse the association of spin with industry sponsorship of research. We included 35 reports, which investigated spin in clinical trials, observational studies, diagnostic accuracy studies, systematic reviews, and meta-analyses. The nature of spin varied according to study design. The highest (but also greatest) variability in the prevalence of spin was present in trials. Some of the common practices used to spin results included detracting from statistically nonsignificant results and inappropriately using causal language. Source of funding was hypothesised by a few authors to be a factor associated with spin; however, results were inconclusive, possibly due to the heterogeneity of the included papers. Further research is needed to assess the impact of spin on readers' decision-making. Editors and peer reviewers should be familiar with the prevalence and manifestations of spin in their area of research in order to ensure accurate interpretation and dissemination of research.Entities:
Mesh:
Year: 2017 PMID: 28892482 PMCID: PMC5593172 DOI: 10.1371/journal.pbio.2002173
Source DB: PubMed Journal: PLoS Biol ISSN: 1544-9173 Impact factor: 8.029
Fig 1PRISMA flowchart of included articles.
Characteristics of included reports (n = 35).
| Study (author, year [reference]) | Study design | Field of research of included studies | Study design of included studies | Time frame of included studies | Study funding source | Author conflict of interest | |
|---|---|---|---|---|---|---|---|
| Alasbali, 2009 [ | Review | 39 | Topical prostaglandin analogues | Meta-analysis; RCT; nonrandomised controlled trial | 2001 to 2007 | None | Yes |
| Altwairgi, 2012 [ | Review | 114 | Systemic therapy in lung cancer | RCT | 2004 to 2009 | Not disclosed | No |
| Arunachalam, 2016 [ | Review | 110 | Surgical trials | RCT | 2013 to 2015 | None | No |
| Boutron, 2010 [ | Cross-sectional | 72 | Not restricted | RCT | Dec 2006 | Government | No |
| Boutron, 2014 [ | RCT | 30 | Oncology | RCT | 2005 to 2009 | Government; not-for-profit organisation | Yes |
| Brody, 2013 [ | Cross-sectional | 15 | Surgical trials | Trials | 2008 | Government | No |
| Brown, 2013 [ | Review | 88 | Obesity | Observational | Not stated | Government | Yes |
| Cofield, 2010 [ | Cross-sectional | 161 | Obesity and nutrition | Observational | 2006 | Government | Yes |
| Cordoba, 2010 [ | Cross-sectional | 40 | Not restricted | Parallel group RCT | 2008 | None | No |
| Djulbegovic, 2011 [ | Systematic review | 374 | Oncology | RCT | 1955 to 2006 | Government | No |
| Fernandez Y Garcia, 2010 [ | Review (longitudinal analysis) | 87 | Not restricted | RCT | 1994, 1999, and 2004 | Industry; government | Yes |
| Gewandter, 2015 [ | Review | 76 | Analgesics | RCT | 2006 to 2013 | Industry; not-for-profit organisation | Yes |
| Hernandez, 2013 [ | Systematic review | 16 | Antiretroviral therapy | Noninferiority RCT | 2000 to 2012 | Not-for-profit organisation | Yes |
| Jefferson, 2009 [ | Systematic review | 274 | Influenza vaccines | RCT; controlled clinical trial; cohort; case-control | Not stated (up to 2006) | Government | Yes |
| Latronico, 2013 [ | Review | 111 | Intensive care | RCT | 2001 to 2010 | Not disclosed | Not disclosed |
| Lazarus, 2015 [ | Review | 128 | Not restricted | Nonrandomised trials | 2011 to 2013 | Not-for-profit organisation | No |
| Le Fourn, 2013 [ | Review | 12 | Pharmacological treatment of autoimmune or idiopathic chronic urticaria | RCT | 1996 to 2011 | Not-for-profit organisation | No |
| Li, 2009 [ | Review | 73 | Quality improvement interventions | Experimental or observational | 2002 to 2003 | Not disclosed | Not disclosed |
| Lieb, 2016 [ | Review | 95 | Psychological therapies for anxiety, depressive, or personality disorders | Systematic review | 2010 to 2013 | University | Yes |
| Lockyer, 2013 [ | Review | 71 | Interventions for foot, leg, or pressure ulcers | RCT | 2004 to 2009 | Government | No |
| Lumbreras, 2009 [ | Cross-sectional | 15 | Molecular diagnostic tests | Diagnostic accuracy study | 2006 | Government | No |
| Mathieu, 2012 [ | Review | 105 | Rheumatology | RCT | 2006 to 2008 | Not disclosed | No |
| Ochodo, 2013 [ | Cross-sectional | 126 | Not restricted | Diagnostic accuracy study | 2010 | Not disclosed | No |
| Patel, 2013 [ | Review | 58 | Laparoscopic lower GI surgery | RCT | 1992 to 2012 | Not disclosed | None |
| Patel, 2015 [ | Review | 38 | Robotic colorectal surgery | RCT, observational | 1992 to 2014 | Not disclosed | Yes |
| Pocock, 1987 [ | Review | 130 | Not restricted | Controlled clinical trial | 1985 to 1986 | Not disclosed | Not disclosed |
| Prasad, 2013 [ | Review | 167 | Not restricted | Observational study | 2010 | Not disclosed | No |
| Roest, 2015 [ | Review (with meta-analysis) | 16 | Second generation antidepressants in treatment of anxiety disorders | Phase 2 and 3 RCT | 1995 to 2009 | Not-for-profit organisation | Yes |
| Tricco, 2009 [ | Cross-sectional | 296 | Not restricted | Systematic review | 2004 | Not-for-profit organisation | Yes |
| Vedula, 2012 [ | Case study | 12 | Off-label uses of gabapentin | RCT | 1987 to 2008 | University | Yes |
| Vera-Badillo, 2013 [ | Review | 92 | Breast cancer | RCT | 1995 to 2011 | Not disclosed | No |
| Wilson, 2011 [ | Review | 10 | Implantable cardioverter defibrillators | Primary prevention trial | 1996 to 2009 | Not disclosed | Not disclosed |
| Yank, 2007 [ | Retrospective cohort | 124 | Antihypertensive drugs | Meta-analysis | 1983 to 2004 | Not-for-profit organisation; university | No |
| Yavchitz, 2016 [ | Instrument development; survey | 122 | N/A | Systematic reviews and meta-analyses | N/A | Not-for-profit organisation; university | No |
| You, 2012 [ | Review | 336 | Oncology (solid tumours) | RCT | 2005 to 2009 | Government; not-for-profit organisation | No |
1 A systematic review was defined as having a structured, replicable, and exhaustive search strategy (no limits on year or source); a review was defined as having an ill-defined or significantly limited search strategy; a cross-sectional study was defined as sampling from a time period of 1 year or less. RCT, randomised controlled trial
Definitions of spin provided by the included reports (n = 35).
| Definition | Example | |
|---|---|---|
| Reporting practices that distort the interpretation of results and create misleading conclusions, suggesting a more favourable result | 20 (57%) | ‘Specific reporting strategies, whatever their motive, to highlight that the experimental treatment is beneficial, despite a statistically nonsignificant difference for the primary outcome, or to distract the reader from statistically nonsignificant results’. [ |
| Discordance between results and their interpretation, with the interpretation more favourable than the results | 9 (26%) | ‘…whether data presented in the study supported the author's conclusions…’ [ |
| Attribution of causality when study design does not support it | 3 | ‘Inappropriate use of causal language in the abstracts and titles of almost one third of human observational obesity or nutrition related study reports…’ [ |
| Overinterpretation or inappropriate extrapolation of results | 3 | ‘We defined overinterpretation as reporting of diagnostic accuracy studies that makes tests look more favorable than the results justify’. [ |
Prevalence of spin in studies assessed in the included reports (n = 31)*.
| Type of study | Subtype of study | Location in study | |
|---|---|---|---|
| Abstract | Main text | ||
| Trials (overall) | 56.8 (9.7–83.6) ( | 56.5 (18.8–100) ( | |
| RCTs (superiority) | 16.3 (9.6–22.9) ( | 34.5 (18.8–83.3) ( | |
| RCTs (superiority) with non-significant primary outcome | 60.5 (40.0–68.1) ( | 60.3 (35.5–71.4) ( | |
| RCTs (superiority) with composite outcome | 55.0 (50.0–82.5) ( | No data | |
| RCTs (non-inferiority) | 62.5 (62.5–62.5) ( | 68.8 (68.8–68.8) ( | |
| Controlled trials (randomized and not) | 75.4 (75.4–75.4) ( | 60.8 (21.6–100.0) ( | |
| Controlled trials (randomized and not) with non-significant primary outcome | 81.6 (81.6–81.6) ( | 58.2 (40.0–76.3) ( | |
| Non-randomized trials | 64.8 (46.1–83.6) ( | 83.9 (82.1–85.6) ( | |
| Observational studies | 30.7 (23.9–38.6) ( | 85.6 (85.6–85.6) ( | |
| Diagnostic accuracy studies | No data | 43.7 (31.0–56.5) ( | |
| Systematic reviews/meta-analyses | No data | 26.3 (24.2–28.4) ( | |
* Not all reports measured spin in the both the abstract and the main text; some reports contained multiple measures of spin prevalence due to multiple definitions of spin.
Fig 2Forest plot of meta-analysis of the association between funding source and presence of spin.